United States · How much has Uniquity Bio raised?
Uniquity Bio has raised $300M across 1 round since 2024.
United States · Series A startup
Who invested in Uniquity Bio
One round we have observed, with the 0 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Follow Uniquity Bio and see its new rounds in your feed. Start following
Funding summaryUpdated 15 Nov 2026
$300Mraised across 1 round since 2024, from 1 source
- Latest round
- Series A, $300MMay 2024
- Investors
- 0
The rounds
- May 2024Series A$300M
No investor was named in the report.
Source recorded
Founders and team
From Uniquity Bio's own website: 9 on the team.
- Jason MooreSenior Vice President, Regulatory & Quality
- Kelly CopelandSenior Vice President, Strategy and Corporate Development
- Kerri Mussari-SmithVice President, Clinical Operations
- Will KanePresident & CEO
- Daniel RudioChief Administrative Officer
- Matthew HartzellChief Financial Officer
- Chad JohnsonSenior Director, Drug Product Manufacturing
- Daniel MiconiDirector, Clinical Operations
- Michael FinkleDirector, Regulatory Operations
Quick answers about Uniquity Bio
When did Uniquity Bio last raise?
Uniquity Bio's most recent round was a Series A of $300M in May 2024.
What was Uniquity Bio's biggest round?
Its most recent round, $300M in May 2024, is also its largest on record.
What stage is Uniquity Bio at?
Uniquity Bio's latest named round is a Series A, in May 2024.
Where is Uniquity Bio based?
Uniquity Bio is based in the United States.
Companies like Uniquity Bio
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.